Uncommon Cures, LLC Begins Operations With Series A Funding To Bring Cost-Effective And Time-Efficient Clinical Trials To The Rare Disease Field. 

Uncommon Cures, LLC, a privately held rare disease clinical research organization (CRO), begins operations after completing its Series A financing led by PilotRock Investments, LLC. Uncommon Cures brings together a…

Uncommon Curess, LLC Is Please To Announce That Dr. Tam Roshan Lal Has Joined The Company As Chief Medical Officer.

For Immediate Release Uncommon Cures, LLC is pleased to announce that Dr. Tam Roshan Lal has joined the company as Chief Medical Officer. Dr. Roshan Lal is an experienced rare disease…

Coming Soon

The link you clicked is currently under construction. Check back soon!